Literature DB >> 15937201

Pathogenesis and treatment of Clostridium difficile infection.

I Tonna1, P D Welsby.   

Abstract

This paper reviews the pathogenesis and management of Clostridium difficile diarrhoea, in particular the management of recurrent episodes.

Entities:  

Mesh：

Year:  2005        PMID： 15937201      PMCID： PMC1743287          DOI： 10.1136/pgmj.2004.028480

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  39 in total

Review 1.  Clostridium difficile-associated diarrhea and colitis.

Authors:  S F Yassin; T M Young-Fadok; N N Zein; D S Pardi
Journal:  Mayo Clin Proc       Date:  2001-07       Impact factor: 7.616

2.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.

Authors:  Mark A Miller; Meagan Hyland; Marianna Ofner-Agostini; Marie Gourdeau; Magued Ishak
Journal:  Infect Control Hosp Epidemiol       Date:  2002-03       Impact factor: 3.254

Review 4.  The pathogenicity of Clostridium difficile.

Authors:  I R Poxton; J McCoubrey; G Blair
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

5.  Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

6.  Intravenous metronidazole for the treatment of Clostridium difficile colitis.

Authors:  F Friedenberg; A Fernandez; V Kaul; P Niami; G M Levine
Journal:  Dis Colon Rectum       Date:  2001-08       Impact factor: 4.585

Review 7.  Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding; S Johnson; L R Peterson; M E Mulligan; J Silva
Journal:  Infect Control Hosp Epidemiol       Date:  1995-08       Impact factor: 3.254

8.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.

Authors:  Lynne V McFarland; Gary W Elmer; Christina M Surawicz
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

Review 9.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

10.  Yoghurt biotherapy: contraindicated in immunosuppressed patients?

Authors:  Gordon MacGregor; A J Smith; B Thakker; J Kinsella
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401
View more
  24 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Mapping interactions between germinants and Clostridium difficile spores.

Authors:  Amber Howerton; Norma Ramirez; Ernesto Abel-Santos
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

4.  Facilely accessible quinoline derivatives as potent antibacterial agents.

Authors:  Peng Teng; Chunhui Li; Zhong Peng; Vanderschouw Anne Marie; Alekhya Nimmagadda; Ma Su; Yaqiong Li; Xingmin Sun; Jianfeng Cai
Journal:  Bioorg Med Chem       Date:  2018-05-22       Impact factor: 3.641

5.  The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.

Authors:  Louis Lteif
Journal:  Hawaii J Med Public Health       Date:  2017-02

6.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

7.  The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.

Authors:  Keshan Zhang; Song Zhao; Yuankai Wang; Xuejun Zhu; Hong Shen; Yugen Chen; Xingmin Sun
Journal:  Anaerobe       Date:  2015-10-13       Impact factor: 3.331

8.  A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.

Authors:  Natalie G Anosova; Leah E Cole; Lu Li; Jinrong Zhang; Anna M Brown; Sophia Mundle; Jianxin Zhang; Satyajit Ray; Fuqin Ma; Pierre Garrone; Nicola Bertraminelli; Harry Kleanthous; Stephen F Anderson
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

9.  Clostridium difficile infection in fever patients with gynecological malignancies.

Authors:  Shintaro Yanazume; Akio Tokudome; Mika Fukuda; Shinichi Togami; Masaki Kamio; Shunichiro Ota; Hiroaki Kobayashi
Journal:  Cancer Rep (Hoboken)       Date:  2019-07-22

10.  Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Shahryar Ahmad; Nilay Kumar; Gagan Kumar; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.